This toolkit is designed to support providers to provide smoking cessation assistance to patients as a routine part of cancer care and includes the following resources: 

• Session recordings and slides from WCLC 2023
• Healthcare Providers, Tobacco Control and Smoking Cessation Brochure
• Links to key guidelines and protocols from the World Health Organization (WHO), US Surgeon General, the Centers for Disease Control and Prevention, and the National Comprehensive Cancer Network (NCCN)
• Journal articles on practice patterns and perceptions of thoracic oncology providers of tobacco use and cessation in cancer patients
• IASLC Position Statement on Tobacco Cessation after a Cancer Diagnosis
• IASLC Policy Statement - Electronic Cigarettes

Supported by the IASLC Tobacco Control and Smoking Cessation Committee.

This activity is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer including medical oncologists, thoracic surgeons, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician assistants.

Upon completion of this activity, the participants should be able to:

• Develop and enhance up-to-date knowledge and competency in tobacco control and smoking cessation.
• Describe how continued smoking after a cancer diagnosis leads to poorer treatment outcomes, increased complications, reduced overall survival and poorer quality of life.
• Recognize the critical importance of screening every patient for tobacco dependency.
• Incorporate smoking cessation support and protocols as a standard part of cancer care.
• Advise patients who use tobacco of the health benefits of quitting.
• Facilitate access to evidence-based smoking cessation resources.
• Explore successful tobacco prevention and control programs in Italy.

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need any assistance with this activity, please email: education@iaslc.org.